ECHA | 55th meeting of the Committee for Risk Assessment | December 2020 | Draft Agenda




The 55th meeting of the Committee for Risk Assessment includes the following items:

Requests under Article 77(3)(c)

1) DNEL development for trixylyl phosphate, for agreement 

2) Revision of derogations from proposed restrictions on:

(*) perfluorooctanoic acid (PFOA), its salts and PFOA-related substances

(*) C9-C14 perfluorocarboxylic acids (C9-C14 PFCA), their salts 

(*) C9-C14 PFCA-related substances For adoption 

3) Classification for acute inhalation toxicity of EGBE for discussion and adoption 

4) Classification for environmental toxicity of lead for discussion


Health based exposure limits at the workplace

(*) Cadmium and its inorganic compounds – first draft opinion


Harmonised classification and labelling (CLH)

- Hazard classes for agreement with plenary debate for discussion and adoption:

1) C. I. Disperse Blue 124  (EC: 239-203-6; CAS: 15141-18-1)

2) Bentazone (ISO) (EC: 246-585-8; CAS: 25057-89-0) 

3) Margosa, ext.  (EC: 283-644-7; CAS: 84696-25-3) 

4) Perfluroheptanoic acid (PFHpA) (EC: 206-798-9; CAS: 375-85-9)

5) Benfluralin (ISO) (EC: 217-465-2; CAS: 1861-40-1) 

6) Bisphenol S (EC: 201-250-5; CAS: 80-09-1) 

7) Melamine (EC: 203-615-4; CAS: 108-78-1)

8) Valifanalate (EC: -; CAS: 283159-90-0) 

9) Isopryrazam  (EC: -; CAS: 881685-58-1)

[...]

Restriction Annex XV dossiers

(*) Undecafluorohexanoic acid (PFHxA), its salts and related substances – third draft opinion

Link to the 55th meeting of the Committee for Risk Assessment


                   

Related News

Loading...